Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00192166
Status:
COMPLETED
Last Update Posted:
2008-12-08
First Post:
2005-09-12
Brief Title:
Trial to Assess Safety Efficacy Tolerability and Immunogenicity of Influenza Virus Vaccine Liquid Formulation CAIV-T Administered Concomitantly With a Combination Live Attenuated Mumps Measles and Rubella Vaccine in Healthy Children Aged 11 - 24 Months
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-10
Start Date Type:
None
Primary Completion Date:
2003-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-12
First Submit QC Date:
September 12 2005
Study First Post Date:
2005-09-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-12-05
Last Update Post Date:
2008-12-08
Last Update Post Date Type:
ESTIMATED